Emerging strategies for the clinical application of rapamycin

被引：13

作者：

Kahan, BD ^{[1
]}

机构：

[1] Univ Texas, Sch Med, Dept Surg, Div Immunol & Organ Transplantat, Houston, TX 77030 USA

来源：

CLINICAL BIOCHEMISTRY | 1998年 / 31卷 / 05期

关键词：

D O I：

10.1016/S0009-9120(98)00044-7

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：341 / 344

页数：4

共 22 条

[1]

ALBERS MW, 1993, J BIOL CHEM, V268, P22825

[2] Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506 [J].

Andoh, TF ;

Burdmann, EA ;

Fransechini, N ;

Houghton, DC ;

Bennett, WM .

KIDNEY INTERNATIONAL, 1996, 50 (04) :1110-1117

[3] Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model [J].

Andoh, TF ;

Lindsley, J ;

Franceschini, N ;

Bennett, WM .

TRANSPLANTATION, 1996, 62 (03) :311-316

[4] EFFECTS OF CYCLOSPORINE THERAPY ON PLASMA-LIPOPROTEIN LEVELS [J].

BALLANTYNE, CM ;

PODET, EJ ;

PATSCH, WP ;

HARATI, Y ;

APPEL, V ;

GOTTO, AM ;

YOUNG, JB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (01) :53-56

[5] CONTROL OF P70 S6 KINASE BY KINASE-ACTIVITY OF FRAP IN-VIVO [J].

BROWN, EJ ;

BEAL, PA ;

KEITH, CT ;

CHEN, J ;

SHIN, TB ;

SCHREIBER, SL .

NATURE, 1995, 377 (6548) :441-446

[6] QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].

CHOU, TC ;

TALALAY, P .

ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55

[7]

GROTH CG, 1997, 23 ANN SCI M AM SOC, pA223

[8] BIOCHEMICAL BACKGROUND OF TRIMETHOPRIM-SULFAMETHOXAZOLE [J].

HITCHINGS, GH .

MEDICAL JOURNAL OF AUSTRALIA, 1973, 1 (02) :5-9

[9]

KAHAN BD, 1995, TRANSPLANTATION, V59, P505

[10] Sirolimus: A new agent for clinical renal transplantation [J].

Kahan, BD .

TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :48-50

← 1 2 3 →